Cargando…
Tumoral Melanosis Associated with Pembrolizumab-Treated Metastatic Melanoma
Tumoral melanosis is a form of completely regressed melanoma that usually presents as darkly pigmented lesions suspicious for malignant melanoma. Histology reveals dense dermal and subcutaneous infiltration of melanophages. Pembrolizumab is an antibody directed against programmed death receptor-1 (P...
Autores principales: | Bari, Omar, Cohen, Philip R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5348220/ https://www.ncbi.nlm.nih.gov/pubmed/28348944 http://dx.doi.org/10.7759/cureus.1026 |
Ejemplares similares
-
Metastatic melanoma with features of blue nevus and tumoral melanosis identified during pembrolizumab therapy
por: Helm, Matthew F., et al.
Publicado: (2017) -
Metastatic Porocarcinoma Effectively Managed by Pembrolizumab
por: Singh, Arminder, et al.
Publicado: (2021) -
Time to Treatment With Nivolumab or Pembrolizumab for Patients With Advanced Melanoma in Everyday Practice
por: Ksienski, Doran, et al.
Publicado: (2021) -
Bilateral, Symmetrical, Congenital Becker’s Nevus Melanosis: A Rare Presentation and Review of the Literature
por: Abdulwahab, Rahaf A, et al.
Publicado: (2023) -
Pembrolizumab-Induced Lichenoid Dermatitis in a Patient With Metastatic Cancer of Unknown Primary
por: Sethi, Ashish, et al.
Publicado: (2021)